Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
18.58
+0.13 (0.70%)
Jan 17, 2025, 4:00 PM EST - Market closed
Innoviva Employees
Innoviva had 112 employees as of December 31, 2023. The number of employees increased by 11 or 10.89% compared to the previous year.
Employees
112
Change (1Y)
11
Growth (1Y)
10.89%
Revenue / Employee
$3,149,509
Profits / Employee
$576,705
Market Cap
1.16B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
INVA News
- 5 weeks ago - Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole) - Business Wire
- 5 weeks ago - Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States - GlobeNewsWire
- 7 weeks ago - Innoviva to Participate in the Citi 2024 Global Healthcare Conference - Business Wire
- 2 months ago - Innoviva to Participate in the UBS Global Healthcare Conference - Business Wire
- 2 months ago - Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress - Business Wire
- 3 months ago - Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024 - Business Wire
- 4 months ago - Innoviva to Participate in Upcoming Investor Conferences - Business Wire
- 6 months ago - Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress - Business Wire